183 related articles for article (PubMed ID: 20185199)
1. The molecular basis of the failed immune response in chronic HBV: therapeutic implications.
Maini MK; Schurich A
J Hepatol; 2010 Apr; 52(4):616-9. PubMed ID: 20185199
[TBL] [Abstract][Full Text] [Related]
2. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of HBV-Specific CD8
Heim K; Neumann-Haefelin C; Thimme R; Hofmann M
Front Immunol; 2019; 10():2240. PubMed ID: 31620140
[TBL] [Abstract][Full Text] [Related]
5. Depletion of CD25+CD4+T cells (Tregs) enhances the HBV-specific CD8+ T cell response primed by DNA immunization.
Furuichi Y; Tokuyama H; Ueha S; Kurachi M; Moriyasu F; Kakimi K
World J Gastroenterol; 2005 Jun; 11(24):3772-7. PubMed ID: 15968737
[TBL] [Abstract][Full Text] [Related]
6. A Highly Attenuated Vesicular Stomatitis Virus-Based Vaccine Platform Controls Hepatitis B Virus Replication in Mouse Models of Hepatitis B.
Moshkani S; Chiale C; Lang SM; Rose JK; Robek MD
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541859
[TBL] [Abstract][Full Text] [Related]
7.
Sung PS; Park DJ; Kim JH; Han JW; Lee EB; Lee GW; Nam HC; Jang JW; Bae SH; Choi JY; Shin EC; Park SH; Yoon SK
Front Immunol; 2019; 10():1319. PubMed ID: 31244857
[TBL] [Abstract][Full Text] [Related]
8. Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation.
Han Q; Lan P; Zhang J; Zhang C; Tian Z
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():132-7. PubMed ID: 23855309
[TBL] [Abstract][Full Text] [Related]
9. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance.
Lan P; Zhang C; Han Q; Zhang J; Tian Z
Hepatology; 2013 Jul; 58(1):73-85. PubMed ID: 23447417
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy and therapeutic vaccines for chronic HBV infection.
Lang-Meli J; Neumann-Haefelin C; Thimme R
Curr Opin Virol; 2021 Dec; 51():149-157. PubMed ID: 34710645
[TBL] [Abstract][Full Text] [Related]
12. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
Li M; Sun X; Zhou Z; Zhang X; Jin S; Gao Y; Gao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
[TBL] [Abstract][Full Text] [Related]
13. Immunological cure of HBV infection.
Lang J; Neumann-Haefelin C; Thimme R
Hepatol Int; 2019 Mar; 13(2):113-124. PubMed ID: 30600480
[TBL] [Abstract][Full Text] [Related]
14. T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection.
Shimizu Y
World J Gastroenterol; 2012 May; 18(20):2443-51. PubMed ID: 22654441
[TBL] [Abstract][Full Text] [Related]
15. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.
Boni C; Fisicaro P; Valdatta C; Amadei B; Di Vincenzo P; Giuberti T; Laccabue D; Zerbini A; Cavalli A; Missale G; Bertoletti A; Ferrari C
J Virol; 2007 Apr; 81(8):4215-25. PubMed ID: 17287266
[TBL] [Abstract][Full Text] [Related]
16. Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?
Koh S; Bertoletti A
Med Microbiol Immunol; 2015 Feb; 204(1):87-94. PubMed ID: 25511870
[TBL] [Abstract][Full Text] [Related]
17. CXCL13-mediated recruitment of intrahepatic CXCR5
Li Y; Tang L; Guo L; Chen C; Gu S; Zhou Y; Ye G; Li X; Wang W; Liao X; Wang Y; Peng X; Liu G; Zhang X; Sun J; Peng J; Hou J
J Hepatol; 2020 Mar; 72(3):420-430. PubMed ID: 31610223
[TBL] [Abstract][Full Text] [Related]
18. Advances in therapeutics for chronic hepatitis B.
Yang N; Bertoletti A
Hepatol Int; 2016 Mar; 10(2):277-85. PubMed ID: 26363922
[TBL] [Abstract][Full Text] [Related]
19. TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.
Martin P; Dubois C; Jacquier E; Dion S; Mancini-Bourgine M; Godon O; Kratzer R; Lelu-Santolaria K; Evlachev A; Meritet JF; Schlesinger Y; Villeval D; Strub JM; Van Dorsselaer A; Marchand JB; Geist M; Brandely R; Findeli A; Boukhebza H; Menguy T; Silvestre N; Michel ML; Inchauspé G
Gut; 2015 Dec; 64(12):1961-71. PubMed ID: 25429051
[TBL] [Abstract][Full Text] [Related]
20. Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B.
Kennedy PTF; Sandalova E; Jo J; Gill U; Ushiro-Lumb I; Tan AT; Naik S; Foster GR; Bertoletti A
Gastroenterology; 2012 Sep; 143(3):637-645. PubMed ID: 22710188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
